Type-2 DM is characterized by insulin and leptin resistance, contributing to hyperglycemia and dyslipidemia, which are associated with altered sympathetic nervous system (SNS) signaling and CV dysfunction [5–8]. This evidence concerns the gene INS and Hyperglycemia.